Results for the Second Quarter 2017

Sales ended at MNOK 69.2 for the quarter (MNOK 67.2). Sales for the 1st half increased by 8.2 % and ended at MOK 143.5 (MNOK 132.7).

Currency neutral growth of own products was 4.7 % and was negatively impacted by delayed flow probe deliveries amounting to MNOK 5.5. Currency neutral growth of own products was 10.7 % for the 1st half. Operating profit (EBIT) for the quarter ended at MNOK 13.6 (MNOK 17.1). Operating profit for the 1st half ended at MNOK 29.7 (MNOK 30.6). Read the full report below.

Financial Report Second Quarter

Medistim ASA Q2 2017 presentation